Stock screener

INSM

Conviction 49HealthcareScan · Tue, Sep 8, 2026
INSM$124.91-1.09%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Josh Gottheimer
2
3
2
Vol MA14 1.72M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
INSMED IncPHARMACEUTICAL PREPARATIONSwww.insmed.com
Price124.91
Change-1.09%
Gap-1.19%
Rel volume0.74×
Avg volume1.8M
Avg $ vol225.92M
SMA 20125.66
SMA 50116.12
SMA 200140.44
Price vs 50+7.57%
Price vs 200-11.06%
MA stackmixed
50/200 cross
Supertrendup · 113.70
RSI (14)55
MACD hist-0.53
MACD cross
Stoch %K / %D56 / 63
ADX (14)22
+DI / −DI26 / 22
RSI divergence
MACD divergence
ATR %+3.77%
ADR %3.30%
52w high211.41
52w low91.88
From 52w high-40.92%
Above 52w low+35.95%
New 52w highNo
SqueezeOff
Bollinger width11.19%
%B0.45
Donchian pos42.75%
Donchian high135.30
Donchian low117.15
AVWAP (52w high)133.87
vs AVWAP high-6.69%
AVWAP (52w low)109.75
vs AVWAP low+13.82%
OBV trendDown
Chaikin MF (20)-0.01
Today vs 20d0.74×
Avg vol (14d)1.72M
Avg vol (20d)1.8M
Avg $ vol (20d)225.92M
Market cap27.28B
RS 3m (vs SPY)+29.61%
RS 6m (vs SPY)-24.42%
RS line new highNo
Trend template3/8
Technical rank30.5
1 week+2.54%
1 month-4.72%
3 months+32.64%
6 months-12.73%
1 year-13.91%
YTD-29.48%
P/E-21.36
P/B36.01
P/S44.98
P/FCF-28.19
EPS-6.42
Div yield
ROE-168.55%
ROA-60.72%
Debt/Eq1.01
Current3.72
EV/EBITDA-22.16
Gross margin18.51%
Net margin-210.54%
Rev growth66.73%
EPS growth-39.73%
Price target201.22
Target upside61.09%
Analyst ratingBuy
Institutional112.57%
Ent. value27.5B
Revenue425.49M
Net income-13.24M
Gross profit33.02M
Free cash flow-967.58M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out216.75M
Employees1.66K
ListedThu, Jun 1, 2000
Free float213.12M
Float %98.9%
Short interest10.89M
Days to cover2.7d
Short volume47.8%
Squeeze score29 / 100
Next earnings
EPS forecast
Last EPS vs est−$0.52 vs −$0.69
Last surprise+24.6% beat
Setup gradeC
Conviction49 / 100
Pattern quality
Tech rank30.5 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance134.40
Support100.75
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in INSM · 6 recent

All disclosures →
MemberSideAmount
Josh Gottheimer
Josh Gottheimer
house · D · NJ · traded 2026-06-10
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-09-22
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-08-08
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2025-07-07
Sell$1K–$15K
Josh Gottheimer
Josh Gottheimer
house · D · NJ · traded 2025-06-16
Buy$1K–$15K
Josh Gottheimer
Josh Gottheimer
house · D · NJ · traded 2025-04-09
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in INSM · 3 buys · 7 sells

InsiderSideShares
SHAROKY MELVIN MD
Director · Common Stock · 2026-08-17
Sell5K
Adsett Roger
Chief Operating Officer · Common Stock · 2026-08-10
Exercise76.6K
Adsett Roger
Chief Operating Officer · Common Stock · 2026-08-10
Exercise80.97K
Adsett Roger
Chief Operating Officer · Common Stock · 2026-08-10
Sell239.85K
Adsett Roger
Chief Operating Officer · Stock Option (right to buy) · 2026-08-10
Exercise82.28K
Adsett Roger
Chief Operating Officer · Stock Option (right to buy) · 2026-08-10
Exercise76.6K
Adsett Roger
Chief Operating Officer · Stock Option (right to buy) · 2026-08-10
Exercise80.97K
Adsett Roger
Chief Operating Officer · Common Stock · 2026-08-10
Exercise82.28K
Flammer Martina M.D.
Chief Medical Officer · Stock Option (right to buy) · 2026-08-06
Exercise18.28K
Flammer Martina M.D.
Chief Medical Officer · Stock Option (right to buy) · 2026-08-06
Exercise8.89K

SEC filings

EDGAR filings in INSM · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.